Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-057789
Filing Date
2017-11-09
Accepted
2017-11-09 16:47:16
Documents
99
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv478140_10q.htm 10-Q 1120345
2 EXHIBIT 31.1 tv478140_ex31-1.htm EX-31.1 11623
3 EXHIBIT 31.2 tv478140_ex31-2.htm EX-31.2 11579
4 EXHIBIT 32.1 tv478140_ex32-1.htm EX-32.1 4888
5 EXHIBIT 32.2 tv478140_ex32-2.htm EX-32.2 4651
  Complete submission text file 0001144204-17-057789.txt   13177983

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fbio-20170930.xml EX-101.INS 3807425
7 XBRL TAXONOMY EXTENSION SCHEMA fbio-20170930.xsd EX-101.SCH 107496
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fbio-20170930_cal.xml EX-101.CAL 70370
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fbio-20170930_def.xml EX-101.DEF 729087
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE fbio-20170930_lab.xml EX-101.LAB 730572
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fbio-20170930_pre.xml EX-101.PRE 783313
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

EIN.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35366 | Film No.: 171191538
SIC: 2834 Pharmaceutical Preparations